Skip to main navigation Skip to search Skip to main content

Novel immune checkpoint blocker approved for the treatment of advanced melanoma

  • Université Paris-Sud
  • Institut national de la santé et de la recherche médicale
  • Centre de Recherche des Cordeliers
  • Université Paris Cité
  • Assistance publique – Hôpitaux de Paris

Research output: Contribution to journalEditorial

34 Scopus citations
Original languageEnglish
Pages (from-to)e967147
JournalOncoimmunology
Volume3
Issue number11
DOIs
StatePublished - Nov 2 2014

Keywords

  • CTLA4
  • Keytruda™
  • PD-1
  • Yervoy™
  • ipilimumab
  • nivolumab

Fingerprint

Dive into the research topics of 'Novel immune checkpoint blocker approved for the treatment of advanced melanoma'. Together they form a unique fingerprint.

Cite this